← Leaderboards
Timothy Hubin
University Of Oklahoma Hlth Sciences Ctr
$660,215
Attributed
$660,215
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $180.6K · FY2007–11$200K$150K$100K$50K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$660,215 · 5
By mechanism
P20$660,215 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- Robert S Mannel$9,366,958
- Joseph Neil Henderson$7,048,873
- Darrin R Akins$44,506,914
- Robert E Anderson$18,948,203
- William Edmund Sonntag$19,602,411
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayPreferenceAntibodiesLigandsPharmaceutical PreparationsMetal ComplexCellsBinding (Molecular Function)Chemokine ReceptorLeadNeoplasm MetastasisMacrocyclic CompoundsCxcr4 GeneCxcr4 ReceptorsDesignFlow CytometryFundingGrantImmuneInhibitor/AntagonistInsightBiologicalInterestProtease Inhibitor
Grant awards (5)
DEVELOPMENT AND SCREENING OF TRANSITION METAL COMPLEXES AS CXCR4 ANTAGONISTS$180,583
P20 · FY2011 · RR · contact PI
DEVELOPMENT AND SCREENING OF TRANSITION METAL COMPLEXES AS CXCR4 ANTAGONISTS$164,459
P20 · FY2010 · RR · contact PI
DEVELOPMENT AND SCREENING OF TRANSITION METAL COMPLEXES AS CXCR4 ANTAGONISTS$124,094
P20 · FY2009 · RR · contact PI
DEVELOPMENT AND SCREENING OF TRANSITION METAL COMPLEXES AS CXCR4 ANTAGONISTS$112,605
P20 · FY2008 · RR · contact PI
DEVELOPMENT AND SCREENING OF TRANSITION METAL COMPLEXES AS CXCR4 ANTAGONISTS$78,474
P20 · FY2007 · RR · contact PI